News

Archived News

2005 2004 2003 2002 2001 2000 1999 1998 1997


12/15/00 Paradigm Group Agrees to Dismiss Lawsuit Against Boston Biomedica
11/20/00 Boston Biomedica Announces the Funding of Panacos Pharmaceuticals
11/15/00 Boston Biomedica Reports Third Quarter Financial Results
10/26/00 Boston Biomedica Awarded US Patent For Using Pressure Cycling Technology (PCT) In Biomolecular Purification Processes
10/18/00 Boston Biomedica Announces the Award of NIH Grant Supporting Panacos Pharmaceuticals' HIV Vaccine Program
10/11/00 Boston Biomedica Awarded Contract for $854,000 to Support Major Hepatitis C Study
09/28/00 Richard T. Schumacher, Founder and CEO of Boston Biomedica, Featured in CEOcast Interview
09/25/00 Boston Biomedica Awarded US Patent for Cell, Virus and Bacteria Disruption (Lysis) Using Pressure Cycling Technology (PCT)
09/21/00 Boston Biomedica and the Consortium for Plasma Science Announce Extension of Research Agreement
09/12/00 Boston Biomedica Awarded US Patent for Extraction of Nucleic Acids from Cells Using Pressure Cycling Technology (PCT)
09/05/00 Boston Biomedica Completes Private Placement of $3 Million of Convertible Debentures
08/31/00 Boston Biomedica, Inc. Announces Development and Validation Of New Tickborne Pathogen Test
08/28/00 Boston Biomedica Announces the Availability of a New Test for Lyme Disease
08/11/00 Boston Biomedica Announces Signing of Cooperative Research and Development Agreement (CRADA) With NIH For Evaluating Use of Pressure Cycling Technology (PCT) in Diagnostics
08/08/00 Boston Biomedica Awarded NIH Grant for Nucleic Acid Extraction and Purification Using Pressure Cycling Technology
08/01/00 Boston Biomedica Announces First Independent Scientific Presentation on Pressure Cycling Technology
07/27/00 Boston Biomedica Announces Second Quarter Financial Results
07/19/00 Boston Biomedica Announces Agreement to Obtain Potential Hepatitis B Virus Inhibitors
06/27/00 Granite Financial Issues Research Report With Buy Opinion on Boston Biomedica (BBII)
06/20/00 Boston Biomedica and The American Red Cross Announce Purchase Agreement Renewal For Quality Control Products
05/15/00 Boston Biomedica Reports First Quarter Financial Results
04/25/00 Boston Biomedica Announces the Award of a $1.5M NIH Grant Supporting Panacos Pharmaceuticals' HIV Drug Discovery Program
03/15/00 Boston Biomedica Issued First Patent for Its Proprietary Pressure Cycling Technology (PCT)
02/29/00 Boston Biomedica Reports Fourth Quarter and Year End 1999 Results
02/28/00 Boston Biomedica Announces Q4 and FY1999 Earnings Release Date and Conference Call
02/24/00 Panacos Pharmaceuticals Forms Its Science and Development Advisory Board
02/17/00 Boston Biomedica Announces Exercise of Warrants For Over $2,000,000
02/14/00 Boston Biomedica Presents HIV and Parvovirus Inactivation Data Utilizing Its Proprietary Pressure Cycling Technology (PCT)
02/09/00 Boston Biomedica Receives FDA 510(k) Clearance For Hiv Antigen Accurun(R) Control
02/03/00 Boston Biomedica Announces Agreement to Obtain HIV-1 Subtype Collection
Contact Us
14 Norfolk Avenue
South Easton, MA 02375
(T) 508-230-1828
(F) 508-230-1829
info@pressurebiosciences.com